Quick summary
Quick summary: Octreotide for injectable suspension; Good manufacturing practices concerns.
Quick summary: Octreotide for injectable suspension; Good manufacturing practices concerns.
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Quick summary: Octreotide for injectable suspension; Good manufacturing practices concerns.
Structured information extracted from the official Health Canada recall notice.
Answers based on the official recall notice.
Official product images from Health Canada.
Starting...
Similar recalls and safety notices.